daclatasvir
Showing 26 - 50 of 60
Hepatitis C Virus Trial in Worldwide (Daclatasvir, Simeprevir, Ribavirin)
Completed
- Hepatitis C Virus
- Daclatasvir
- +2 more
-
San Francisco, California
- +25 more
Jan 10, 2017
Hepatitis C Virus Genotype 4 Infection Trial in France (Asunaprevir, Daclatasvir, Ribavirin)
Completed
- Hepatitis C Virus Genotype 4 Infection
- Asunaprevir
- +3 more
-
Bobigny, France
- +24 more
Jan 23, 2017
Hepatitis C, Cirrhosis Trial in Tehran (Sofosbuvir, Daclatasvir, Ribavirin)
Completed
- Hepatitis C
- Cirrhosis
- Sofosbuvir
- +2 more
-
Tehran, Iran, Islamic Republic ofShariati Hospital
Oct 16, 2016
Hepatitis C, Chronic, Hepatocellular Carcinoma Trial in Cairo (Sofosbuvir, Ribavirin, Simeprevir)
Unknown status
- Hepatitis C, Chronic
- Hepatocellular Carcinoma
- Sofosbuvir
- +4 more
-
Cairo, EgyptAmr Maged
May 11, 2016
Hepatitis C Trial in San Antonio (Daclatasvir, Darunavir, Ritonavir)
Completed
- Hepatitis C
- Daclatasvir
- +3 more
-
San Antonio, TexasHealthcare Discoveries, Llc D/B/A Icon Development Solutions
Oct 29, 2015
Hepatitis C Trial in Canada, France (Daclatasvir, Sofosbuvir, Ribavirin)
Withdrawn
- Hepatitis C
- Daclatasvir
- +2 more
-
Calgary, Alberta, Canada
- +11 more
Jan 14, 2016
Chronic Hepatitis C Trial in Worldwide (Daclatasvir, Sofosbuvir, Ribavirin)
No longer available
- Chronic Hepatitis C
- Daclatasvir
- +2 more
-
Amstetten, Austria
- +57 more
Jan 26, 2016
Hepatitis C Infection Trial in France, United States (Daclatasvir, Placebo, Peginterferon alpha-2a)
Completed
- Hepatitis C Infection
- Daclatasvir
- +3 more
-
Montgomery, Alabama
- +13 more
Sep 23, 2015
Chronic Hepatitis C Trial in United States (Daclatasvir, Placebo)
Completed
- Chronic Hepatitis C
- Daclatasvir
- Placebo
-
Anaheim, California
- +6 more
Oct 20, 2015
Chronic Hepatitis C Trial in Puerto Rico, United States (Daclatasvir, Placebo)
Completed
- Chronic Hepatitis C
- Daclatasvir
- Placebo
-
Anaheim, California
- +7 more
Sep 16, 2015
Hepatitis C Infection Trial in Japan (Daclatasvir, Placebo, Peginterferon alfa-2a)
Completed
- Hepatitis C Infection
- Daclatasvir
- +3 more
-
Chiba-Shi, Chiba, Japan
- +5 more
Aug 13, 2015
Hepatitis C Virus Infection Trial in Japan (Daclatasvir, Asunaprevir, DCV 3DAA)
Completed
- Hepatitis C Virus Infection
- Daclatasvir
- +5 more
-
Nagoya-shi, Aichi, Japan
- +34 more
Sep 16, 2015
Chronic Hepatitis C Trial in Rotterdam (Daclatasvir, asunaprevir)
Completed
- Chronic Hepatitis C
- Daclatasvir
- asunaprevir
-
Rotterdam, NetherlandsErasmus Medical Center
Oct 16, 2015
Hepatitis C Virus Infection Trial in Worldwide (Daclatasvir, Asunaprevir, Pegylated interferon alfa-2a)
Completed
- Hepatitis C Virus Infection
- Daclatasvir
- +3 more
-
Montgomery, Alabama
- +106 more
Apr 21, 2016
Hepatitis C Virus Infection Trial in Japan (Daclatasvir, Asunaprevir, Ribavirin)
Completed
- Hepatitis C Virus Infection
- Daclatasvir
- +4 more
-
Nagoya-shi, Aichi, Japan
- +47 more
Sep 23, 2015
Hepatitis C Virus Trial in Worldwide (Daclatasvir, Placebo, peg-interferon alfa-2a)
Completed
- Hepatitis C Virus
- Daclatasvir
- +3 more
-
Montgomery, Alabama
- +63 more
Sep 23, 2015
Hepatitis C Trial in San Antonio (Pegylated Interferon Lambda, Ribasphere, Daclatasvir)
Completed
- Hepatitis C
- Pegylated Interferon Lambda
- +2 more
-
San Antonio, TexasAlamo Medical Research
Sep 23, 2015